{
  "ticker": "OSX",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02970870",
  "id": "02970870",
  "pages": 3,
  "price_sensitive": false,
  "date": "20250721",
  "time": "0832",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250721/pdf/06lz6bnp1q7hj8.pdf",
  "summary": "**Summary:**  \n- **Clinical Trial Approval:** Osteopore\u2019s maxillomandibular reconstruction study at Princess Alexandra Hospital has received Research Governance Office (RGO) clearance.  \n- **Timing:** First patient recruitment expected in 4 weeks (targeting at least 10 patients by 2028).  \n- **Focus:** Evaluates safety/tolerability of Osteopore\u2019s PCL-TCP scaffold for jawbone regeneration.  \n\n*No material trading or capital markets impact identified.*",
  "usage": {
    "prompt_tokens": 1420,
    "completion_tokens": 103,
    "total_tokens": 1523,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-20T22:52:04.768414"
}